
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Oncology Today with Dr Neil Love
00:00
Imlunestrant Plus Abemaciclib Combination
Discussion of EMBER-3 combination arm showing prolonged PFS with imlunestrant plus abemaciclib and real-world access challenges.
Play episode from 35:59
Transcript


